FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Angulo

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Livers

Procedures

Concepts & Ideas

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Kelly A Walsh; Paul Angulo; Timothy M Clifford; Yevgeniya Gokun; Jonathan C Hundley; Daniel A Lewis; George A Davis
Risk factors for venous thromboembolism in patients with chronic liver disease.
Flavia D Mendes; Schuyler O Sanderson; Ayako Suzuki; Keith D Lindor; Paul Angulo
Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease.
Garfield A Grandison; Paul Angulo
Can NASH be diagnosed, graded, and staged noninvasively?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Angulo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kelly A Walsh; Paul Angulo; Timothy M Clifford; Yevgeniya Gokun; Jonathan C Hundley; Daniel A Lewis; George A Davis
Risk factors for venous thromboembolism in patients with chronic liver disease.
The Annals of pharmacotherapy 2013;47(3):333-9.
2012: Flavia D Mendes; Schuyler O Sanderson; Ayako Suzuki; Keith D Lindor; Paul Angulo
Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012;10(9):1028-33.e2.
2012: Garfield A Grandison; Paul Angulo
Can NASH be diagnosed, graded, and staged noninvasively?
Clinics in liver disease 2012;16(3):567-85.
2012: Roberto Gedaly; Jonathan Hundley; Paul Angulo; Changguo Chen; Michael F Daily; B Mark Evers
PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
The Journal of surgical research 2012;176(2):542-8.
2012: Roberto Gedaly; Jonathan Hundley; Malay Shah; Brett T Spear; Paul Angulo; Changguo Chen; Kate Townsend Creasy; Michael F Daily; B Mark Evers
The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.
Anticancer research 2012;32(7):2531-6.
2012: Phunchai Charatcharoenwitthaya; Keith D Lindor; Paul Angulo
The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease.
Digestive diseases and sciences 2012;57(7):1925-31.
2012: sombat treeprasertsuk; Leon A Adams; Scott Leverage; Keith D Lindor; Jennifer St Sauver; Paul Angulo
The Framingham risk score and heart disease in nonalcoholic fatty liver disease.
Liver international : official journal of the International Association for the Study of the Liver 2012;32(6):945-50.
2012: Benjamin C Bryson; Paul Angulo
Cryoglobulins in nonalcoholic Fatty-liver disease: what is the association?
Gastroenterology & hepatology 2012;8(4):281-3.
2011: neeraj bhala; Elisabetta Bugianesi; Phunchai Charatcharoenwitthaya; Christopher P Day; Jason M Hui; Eric Lee; Giorgio Saracco; Joanne H Topping; David van der Poorten; Leon A Adams; Paul Angulo; Jacob George
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.
Hepatology (Baltimore, Md.) 2011;54(4):1208-16.
2011: Roberto Gedaly; Paul Angulo; Michael F Daily; Daniel Davenport; Alvaro Koch; Patrick P McHugh; Jonathan C Hundley
Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.
Archives of surgery (Chicago, Ill. : 1960) 2011;146(8):953-8.
2011: Paul Angulo
Clinical trials: Trial design in NASH--realities and challenges.
Nature reviews. Gastroenterology & hepatology 2011;8(8):424-5.
2011: Scott C Leverage; Paul Angulo
Nonalcoholic fatty liver disease: what are the odds your patient will get a transplant?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(8):631-2.
2011: Ahmad H Ali; Paul Angulo; Roberta A Jorgensen; Marina G Silveira; Emmanouil Sinakos; Keith D Lindor
Varices in early histological stage primary biliary cirrhosis.
Journal of clinical gastroenterology 2011;45(7):e66-71.
2011: Paul Angulo
Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts.
Hepatology (Baltimore, Md.) 2011;53(6):1792-4.
2011: Christine Carter-Kent; Elizabeth M Brunt; Lisa M Yerian; Naim Alkhouri; Paul Angulo; Rohit Kohli; Simon C Ling; Stavra A Xanthakos; Peter F Whitington; Phunchai Charatcharoenwitthaya; Jason Yap; Rocio Lopez; Arthur J McCullough; Ariel E Feldstein
Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.
Journal of pediatric gastroenterology and nutrition 2011;52(2):190-7.
2011: Paul Angulo; Garfield A Grandison; Derek G Fong; Jill C Keach; Keith D Lindor; Einar Bjornsson; Alvaro Koch
Bone disease in patients with primary sclerosing cholangitis.
Gastroenterology 2011;140(1):180-8.
2010: Leon A Adams; Scott Harmsen; Jennifer L St Sauver; Phunchai Charatcharoenwitthaya; Felicity B Enders; Terry Therneau; Paul Angulo
Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.
The American journal of gastroenterology 2010;105(7):1567-73.
2010: Phunchai Charatcharoenwitthaya; Jayant A Talwalkar; Paul Angulo; Andrea A Gossard; Jill C Keach; Janice L Petz; Roberta Jorgensen; Keith D Lindor
Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Digestive diseases and sciences 2010;55(2):476-83.
2009: Manal F Abdelmalek; Schuyler O Sanderson; Paul Angulo; Consuelo Soldevila-Pico; Chen Liu; Joy Peter; Jill Keach; Matt Cave; Theresa Chen; Craig J McClain; Keith D Lindor
Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial.
Hepatology (Baltimore, Md.) 2009;50(6):1818-26.
2009: Christine Carter-Kent; Lisa M Yerian; Elizabeth M Brunt; Paul Angulo; Rohit Kohli; Simon C Ling; Stavra A Xanthakos; Peter F Whitington; Phunchai Charatcharoenwitthaya; Jason Yap; Rocio Lopez; Arthur J McCullough; Ariel E Feldstein
Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.
Hepatology (Baltimore, Md.) 2009;50(4):1113-20.
2008: Paul Angulo; Roberta Jorgensen; Kris V Kowdley; Keith D Lindor
Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study.
Digestive diseases and sciences 2008;53(6):1716-20.
2008: Michael Charlton; Paul Angulo; Naga Chalasani; Ralph Merriman; Kimberly Viker; Phunchai Charatcharoenwitthaya; Schuyler Sanderson; Samer Gawrieh; Anuradha Krishnan; Keith D Lindor
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2008;47(2):484-92.
2008: Phunchai Charatcharoenwitthaya; Paul Angulo; Felicity B Enders; Keith D Lindor
Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 2008;47(1):133-42.
2007: Ayako Suzuki; Paul Angulo; Jennifer St Sauver; Ayako Muto; Toshihide Okada; Keith D Lindor
Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia.
The American journal of gastroenterology 2007;102(9):1912-9.
2007: Einar Björnsson; Paul Angulo
Hepatitis C and steatosis.
Archives of medical research 2007;38(6):621-7.
2007: Einar Björnsson; Paul Angulo
Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.
The American journal of gastroenterology 2007;102(8):1677-82.
2007: Marina G Silveira; Jayant A Talwalkar; Paul Angulo; Keith D Lindor
Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes.
The American journal of gastroenterology 2007;102(6):1244-50.
2007: Paul Angulo; Jason M Hui; Giulio Marchesini; Elisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity B Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith D Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James G Kench; Terry M Therneau; Christopher P Day
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.
Hepatology (Baltimore, Md.) 2007;45(4):846-54.
2007: Phunchai Charatcharoenwitthaya; Cynthia Levy; Paul Angulo; Jill C Keach; Roberta Jorgensen; Keith D Lindor
Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(2):220-6.
2007: Ayako Suzuki; James F Lymp; Jessica Donlinger; Flavia D Mendes; Paul Angulo; Keith D Lindor
Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(2):259-64.
2007: Flavia D Mendes; Cynthia Levy; Felicity B Enders; Edward V Loftus; Paul Angulo; Keith D Lindor
Abnormal hepatic biochemistries in patients with inflammatory bowel disease.
The American journal of gastroenterology 2007;102(2):344-50.
2007: Aldo Montaño-Loza; Paul Angulo
[Auto-antibodies in liver disease].
Revista de gastroenterología de México 2007;72(1):62-8.
2006: Ayako Suzuki; James F Lymp; Jenny St Sauver; Paul Angulo; Keith D Lindor
Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(10):1209-16.
2006: Paul Angulo
NAFLD, obesity, and bariatric surgery.
Gastroenterology 2006;130(6):1848-52.
2006: Leon A Adams; Paul Angulo; Susan C Abraham; Heidi Torgerson; David J Brandhagen
The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(3):298-304.
2006: Paul Angulo
Nonalcoholic fatty liver disease and liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(4):523-34.
2005: Ayako Suzuki; Keith D Lindor; Jenny St Saver; James F Lymp; Flavia D Mendes; Ayako Muto; Toshihide Okada; Paul Angulo
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.
Journal of hepatology 2005;43(6):1060-6.
2005: Paul Angulo
Nonalcoholic fatty liver disease.
Revista de gastroenterología de México 2005;70 Suppl 3():52-6.
2005: Paul Angulo
[Cholestatic syndromes].
Revista de gastroenterología de México 2005;70 Suppl 3():45-51.
2005: Claudia O Zein; Roberta Jorgensen; Bart Clarke; Doris E Wenger; Jill C Keach; Paul Angulo; Keith D Lindor
Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.
Hepatology (Baltimore, Md.) 2005;42(4):762-71.
2005: Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel E Feldstein; Paul Angulo
The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
Gastroenterology 2005;129(1):113-21.
2005: Andrea A Gossard; Paul Angulo; Keith D Lindor
Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.
The American journal of gastroenterology 2005;100(6):1330-3.
2005: Ariel E Feldstein; Bettina G Papouchado; Paul Angulo; Schyler Sanderson; Leon Adams; Gregory J Gores
Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(4):384-9.
2005: Leon A Adams; Paul Angulo; Keith D Lindor
Nonalcoholic fatty liver disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;172(7):899-905.
2005: Cynthia Levy; Denise M Harnois; Paul Angulo; Roberta Jorgensen; Keith D Lindor
Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(1):117-21.
2005: Jayant A Talwalkar; Paul Angulo; Jill C Keach; Janice L Petz; Roberta Jorgensen; Keith D Lindor
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Journal of clinical gastroenterology 2005;39(2):168-71.
2005: Jayant A Talwalkar; Paul Angulo; Jill C Keach; Janice L Petz; Roberta Jorgensen; Keith D Lindor
Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
The American journal of gastroenterology 2005;100(2):308-12.
2005: Ayako Suzuki; Paul Angulo; James F Lymp; Jennifer St Sauver; Ayako Muto; Toshihide Okada; Keith D Lindor
Chronological development of elevated aminotransferases in a nonalcoholic population.
Hepatology (Baltimore, Md.) 2005;41(1):64-71.
2005: Leon A Adams; Schuyler Sanderson; Keith D Lindor; Paul Angulo
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
Journal of hepatology 2005;42(1):132-8.
2004: Paul Angulo; Laura M Alba; Lydia M Petrovic; Leon A Adams; Keith D Lindor; Michael D Jensen
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
Journal of hepatology 2004;41(6):943-9.
2004: Leon A Adams; Claudia O Zein; Paul Angulo; Keith D Lindor
A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.
The American journal of gastroenterology 2004;99(12):2365-8.
2004: Paul Angulo
[Fatty liver and steatotic non-alcoholic hepatitis].
Revista de gastroenterología de México 2004;69 Suppl 3():140-8.
2004: Jayant A Talwalkar; Paul Angulo; C Daniel Johnson; Bret T Petersen; Keith D Lindor
Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 2004;40(1):39-45.
2004: Leon A Adams; Keith D Lindor; Paul Angulo
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease.
The American journal of gastroenterology 2004;99(7):1316-20.
2004: Leon A Adams; Ariel E Feldstein; Keith D Lindor; Paul Angulo
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.
Hepatology (Baltimore, Md.) 2004;39(4):909-14.
2004: Ahmad S Abdulkarim; Lydia M Petrovic; W Ray Kim; Paul Angulo; Ricardo V Lloyd; Keith D Lindor
Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?
Journal of hepatology 2004;40(3):380-4.
2004: Kelly W Burak; Paul Angulo; Tousif M Pasha; Kathleen Egan; Janice L Petz; Keith D Lindor
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
The American journal of gastroenterology 2004;99(3):523-6.
2004: Keith D Lindor; Kris V Kowdley; E Jenny Heathcote; M Edwyn Harrison; Roberta Jorgensen; Paul Angulo; James F Lymp; Lawrence J Burgart; Patrick Colin
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
Hepatology (Baltimore, Md.) 2004;39(3):770-8.
2004: Claudia O Zein; Keith D Lindor; Paul Angulo
Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 2004;39(1):204-10.
2003: Joanna L Siegel; Harvinder Luthra; Jessica Donlinger; Paul Angulo; Keith D Lindor
Association of primary biliary cirrhosis and rheumatoid arthritis.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2003;9(6):340-3.
2003: Jason R Phillips; Paul Angulo; Keith D Lindor
Recurrent idiopathic hepatitis: a new entity?
Journal of clinical gastroenterology 2003;37(3):267-9.
2003: Ariel E Feldstein; Ali Canbay; Paul Angulo; Makiko Taniai; Lawrence J Burgart; Keith D Lindor; Gregory J Gores
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.
Gastroenterology 2003;125(2):437-43.
2003: Joanna L Siegel; Roberta Jorgensen; Paul Angulo; Keith D Lindor
Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis.
Journal of clinical gastroenterology 2003;37(2):183-5.
2003: Ariel E Feldstein; Jean Perrault; Mounif El-Youssif; Keith D Lindor; Deborah K Freese; Paul Angulo
Primary sclerosing cholangitis in children: a long-term follow-up study.
Hepatology (Baltimore, Md.) 2003;38(1):210-7.
2003: Kelly W Burak; Paul Angulo; Keith D Lindor
Is there a role for liver biopsy in primary sclerosing cholangitis?
The American journal of gastroenterology 2003;98(5):1155-8.
2003: Paul Angulo
Current best treatment for non-alcoholic fatty liver disease.
Expert opinion on pharmacotherapy 2003;4(5):611-23.
2003: K V Narayanan Menon; Paul Angulo; Gwen M Boe; Keith D Lindor
Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis.
The American journal of gastroenterology 2003;98(4):889-92.
2003: Claudia O Zein; Paul Angulo; Keith D Lindor
When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2003;1(2):89-95.
2002: Paul Angulo; Keith D Lindor
Treatment of non-alcoholic steatohepatitis.
Best practice & research. Clinical gastroenterology 2002;16(5):797-810.
2002: Roberta Jorgensen; Paul Angulo; E Rolland Dickson; Keith D Lindor
Results of long-term ursodiol treatment for patients with primary biliary cirrhosis.
The American journal of gastroenterology 2002;97(10):2647-50.
2002: Laura M Alba; Paul Angulo; Keith D Lindor
Primary sclerosing cholangitis.
Minerva gastroenterologica e dietologica 2002;48(2):99-113.
2002: Ayako Suzuki; Judith A van de Water; M Eric Gershwin; Roberta Jorgensen; Paul Angulo; Keith D Lindor
Oral tolerance and pyruvate dehydrogenase in patients with primary biliary cirrhosis.
Developmental immunology 2002;9(2):55-61.
2002: Paul Angulo; Yaakov Maor-Kendler; Keith D Lindor
Small-duct primary sclerosing cholangitis: a long-term follow-up study.
Hepatology (Baltimore, Md.) 2002;35(6):1494-500.
2002: Jayant A Talwalkar; Jill C Keach; Paul Angulo; Keith D Lindor
Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system.
The American journal of gastroenterology 2002;97(5):1191-7.
2002: Paul Angulo
Nonalcoholic fatty liver disease.
The New England journal of medicine 2002;346(16):1221-31.
2002: Paul Angulo; Keith D Lindor
Non-alcoholic fatty liver disease.
Journal of gastroenterology and hepatology 2002;17 Suppl():S186-90.
2002: Paul Angulo
Use of ursodeoxycholic acid in patients with liver disease.
Current gastroenterology reports 2002;4(1):37-44.
2002: Paul Angulo
Treatment of nonalcoholic fatty liver disease.
Annals of hepatology 2002;1(1):12-9.
2002: Paul Angulo; Robert L MacCarty; Pamela B Sylvestre; Roberta Jorgensen; Russell H Wiesner; Nicholas A LaRusso; Keith D Lindor
Pirfenidone in the treatment of primary sclerosing cholangitis.
Digestive diseases and sciences 2002;47(1):157-61.
2001: Paul Angulo; Roberta Jorgensen; Keith D Lindor
Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?
The American journal of gastroenterology 2001;96(11):3152-7.
2001: V Nehra; Paul Angulo; Alan L Buchman; Keith D Lindor
Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis.
Digestive diseases and sciences 2001;46(11):2347-52.
2001: Paul Angulo; O El-Amin; Herschel A Carpenter; Keith D Lindor
Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis.
The American journal of gastroenterology 2001;96(10):3021-7.
2001: K V Narayanan Menon; Paul Angulo; S Weston; E Rolland Dickson; Keith D Lindor
Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.
Journal of hepatology 2001;35(3):316-23.
2001: J R Phillips; Paul Angulo; Tanya M Petterson; Keith D Lindor
Fat-soluble vitamin levels in patients with primary biliary cirrhosis.
The American journal of gastroenterology 2001;96(9):2745-50.
2001: M F Abdelmalek; Paul Angulo; Roberta Jorgensen; Pamela B Sylvestre; Keith D Lindor
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
The American journal of gastroenterology 2001;96(9):2711-7.
2001: Paul Angulo; Keith D Lindor
Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus.
The American journal of gastroenterology 2001;96(5):1631-4.
2001: Denise M Harnois; Paul Angulo; Roberta Jorgensen; Nicholas F LaRusso; Keith D Lindor
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
The American journal of gastroenterology 2001;96(5):1558-62.
2001: M Kaya; Piet C de Groen; Paul Angulo; David M Nagorney; L L Gunderson; Gregory J Gores; Michael G Haddock; Keith D Lindor
Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience.
The American journal of gastroenterology 2001;96(4):1164-9.
2001: M Kaya; Bret T Petersen; Paul Angulo; Todd H Baron; J C Andrews; Christopher J Gostout; Keith D Lindor
Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis.
The American journal of gastroenterology 2001;96(4):1059-66.
2000: Paul Angulo; tushar patel; Roberta Jorgensen; Terry M Therneau; Keith D Lindor
Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Hepatology (Baltimore, Md.) 2000;32(5):897-900.
2000: M Kaya; Paul Angulo; Keith D Lindor
Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system.
Journal of hepatology 2000;33(4):537-42.
2000: Paul Angulo; D H Pearce; C Daniel Johnson; J J Henry; Nicholas F LaRusso; Bret T Petersen; Keith D Lindor
Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis.
Journal of hepatology 2000;33(4):520-7.
2000: Derek G Fong; Paul Angulo; Lawrence J Burgart; Keith D Lindor
Cetirizine-induce cholestasis.
Journal of clinical gastroenterology 2000;31(3):250-3.
2000: Paul Angulo; Keith D Lindor
Medical treatment for primary sclerosing cholangitis: risk versus benefit.
Hepatology (Baltimore, Md.) 2000;32(4 Pt 1):871-2.
2000: Paul Angulo; Kenneth P Batts; Roberta Jorgensen; N A LaRusso; Keith D Lindor
Oral budesonide in the treatment of primary sclerosing cholangitis.
The American journal of gastroenterology 2000;95(9):2333-7.
2000: Paul Angulo; E Rolland Dickson
The timing of liver transplantation in primary biliary cirrhosis.
Baillière's best practice & research. Clinical gastroenterology 2000;14(4):657-68.
2000: Paul Angulo; James B Peter; M Eric Gershwin; CK DeSotel; YY Shoenfeld; Alaa Ahmed; Keith D Lindor
Serum autoantibodies in patients with primary sclerosing cholangitis.
Journal of hepatology 2000;32(2):182-7.
2000: Paul Angulo; Roberta Jorgensen; Jill C Keach; E Rolland Dickson; Coleman Smith; Keith D Lindor
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Hepatology (Baltimore, Md.) 2000;31(2):318-23.
1999: Paul Angulo; Jill C Keach; Kenneth P Batts; Keith D Lindor
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 1999;30(6):1356-62.
1999: Paul Angulo; D R Larson; Terry M Therneau; Nicholas F LaRusso; Kenneth P Batts; Keith D Lindor
Time course of histological progression in primary sclerosing cholangitis.
The American journal of gastroenterology 1999;94(11):3310-3.
1999: Paul Angulo; Keith D Lindor
Primary biliary cirrhosis and primary sclerosing cholangitis.
Clinics in liver disease 1999;3(3):529-70.
1999: Paul Angulo; Keith D Lindor
Primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 1999;30(1):325-32.
1999: Paul Angulo; E Rolland Dickson; Terry M Therneau; Roberta Jorgensen; Coleman Smith; CK DeSotel; S M Lange; M L Anderson; D W Mahoney; Keith D Lindor
Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial.
Journal of hepatology 1999;30(5):830-5.
1999: Paul Angulo; Keith D Lindor; Terry M Therneau; Roberta Jorgensen; Michael Malinchoc; Patrick S Kamath; E Rolland Dickson
Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid.
Liver 1999;19(2):115-21.
1999: Paul Angulo; A E Bharucha; Roberta Jorgensen; CK DeSotel; William J Sandborn; Nicholas F LaRusso; Keith D Lindor
Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study.
Digestive diseases and sciences 1999;44(3):602-7.
1999: Paul Angulo; Kenneth P Batts; Terry M Therneau; Roberta Jorgensen; E Rolland Dickson; Keith D Lindor
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1999;29(3):644-7.
1998: Paul Angulo; Terry M Therneau; A Jorgensen; CK DeSotel; Kathleen S Egan; E Rolland Dickson; J Eileen Hay; Keith D Lindor
Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.
Journal of hepatology 1998;29(5):729-35.
1998: Paul Angulo; Keith D Lindor
Management of primary biliary cirrhosis and autoimmune cholangitis.
Clinics in liver disease 1998;2(2):333-51, ix.